Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/1759-7714.13498 http://scihub22266oqcxt.onion/10.1111/1759-7714.13498 32469164!7283707!32469164     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Thorac+Cancer 2020 ; 11 (7): 2067-2074 Nephropedia Template TP {{tp|p=32469164|t=2020. Clinical recommendations on lung cancer management during the COVID-19 pandemic |pdf=|usr=}}{{32469164}} gab.com Text Clinical recommendations on lung cancer management during the COVID-19 pandemic JO: Thorac Cancer http://www.kidney.de/pget.php?&tw=1&pmid=32469164 #FOAvip Coronavirus disease 2019 (COVID-19) is spreading worldwide, and has been declared as an international public health concern. Patients with lung cancer are highly susceptible to infection compared to healthy individuals because of systemic immunosuppression induced by malignancy and anticancer therapy. Furthermore, patients with cancer demonstrate poorer outcomes following infection. Hence, patients with lung cancer should be considered a priority group for COVID-19 prevention. Furthermore, the routine treatment of patients with cancer has been affected during the COVID-19 pandemic, and patients may not have been able to undergo timely and effective antitumor treatment, thereby indicating a poor prognosis. Here, we provide some suggestions for early identification of COVID-19 and differential diagnosis in patients with lung cancer who have fever and respiratory symptoms. Our medical team also provide clinical recommendations on lung cancer management during the COVID-19 pandemic, for carrying out meticulous and individualized clinical management of lung cancer patients and maximum protection to effectively prevent COVID-19. KEY POINTS: Significant findings of the study This article provides suggestions for early identification of COVID-19 and differential diagnosis in patients with lung cancer with fever and respiratory symptoms. What this study adds This article makes clinical recommendations on lung cancer management during the COVID-19 pandemic. Twit Text FOAVip Clinical recommendations on lung cancer management during the COVID-19 pandemic ????Thorac Cancer http://www.kidney.de/pget.php?&tw=1&pmid=32469164 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32469164 #FOAvip English Wikipedia <ref>{{Cite pmid|32469164}}</ref> Clinical recommendations on lung cancer management during the COVID-19 pandemic #MMPMID32469164 Xu Y; Liu H; Hu K; Wang M Thorac Cancer 2020[Jul]; 11 (7): 2067-2074 PMID32469164show ga Coronavirus disease 2019 (COVID-19) is spreading worldwide, and has been declared as an international public health concern. Patients with lung cancer are highly susceptible to infection compared to healthy individuals because of systemic immunosuppression induced by malignancy and anticancer therapy. Furthermore, patients with cancer demonstrate poorer outcomes following infection. Hence, patients with lung cancer should be considered a priority group for COVID-19 prevention. Furthermore, the routine treatment of patients with cancer has been affected during the COVID-19 pandemic, and patients may not have been able to undergo timely and effective antitumor treatment, thereby indicating a poor prognosis. Here, we provide some suggestions for early identification of COVID-19 and differential diagnosis in patients with lung cancer who have fever and respiratory symptoms. Our medical team also provide clinical recommendations on lung cancer management during the COVID-19 pandemic, for carrying out meticulous and individualized clinical management of lung cancer patients and maximum protection to effectively prevent COVID-19. KEY POINTS: Significant findings of the study This article provides suggestions for early identification of COVID-19 and differential diagnosis in patients with lung cancer with fever and respiratory symptoms. What this study adds This article makes clinical recommendations on lung cancer management during the COVID-19 pandemic. |*Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |China/epidemiology[MESH] |Clinical Laboratory Techniques/methods[MESH] |Comorbidity[MESH] |Coronavirus Infections/*diagnosis/epidemiology/prevention & control[MESH] |Elective Surgical Procedures[MESH] |Fever/virology[MESH] |Humans[MESH] |Lung Neoplasms/epidemiology/*therapy/virology[MESH] |Molecular Targeted Therapy[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/*diagnosis/epidemiology/prevention & control[MESH]Clinical recommendations on lung cancer management during the COVID-19(epmc).pdf DeepDyve Pubget Overpricing